← Leaderboards
Adam Lacy-Hulbert
Ohio State University
$10,392,021
Attributed
$12,894,401
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,894,401 · 14
By mechanism
R01$6,694,518 · 4
R33$3,029,177 · 2
R21$1,888,762 · 4
U01$772,657 · 1
R56$499,631 · 2
R13$9,656 · 1
Top collaborators
- Lynda Stuart5 shared
- Georgios I Papachristou3 shared
- Oliver James Harrison2 shared
- James Daniel Lord2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingInfectionPreventResponsePathway InteractionsImmuneCytokineInflammationImmune SystemImmunityGenerationsChronicCell DeathUnited States National Institutes Of HealthInflammatoryBaseLeadGenesVirusSignal TransductionResistanceAffectRegulation
Grant awards (30)
LITAF regulation of membrane repair and inflammation$835,708
R01 · FY2025 · AI · contact PI
Regulation of Intestinal Immunity and Repair by Integrins$735,511
R01 · FY2025 · DK · contact PI
Immune Signatures and Clinical Outcomes in Acute Pancreatitis$680,769
R01 · FY2025 · DK
DCs as clinical targets of anti-integrin therapy in IBD$210,126
R21 · FY2025 · AI
LITAF regulation of membrane repair and inflammation$835,708
R01 · FY2024 · AI · contact PI
Regulation of Intestinal Immunity and Repair by Integrins$750,588
R01 · FY2024 · DK · contact PI
Immune Signatures and Clinical Outcomes in Acute Pancreatitis$656,955
R01 · FY2024 · DK
DCs as clinical targets of anti-integrin therapy in IBD$259,950
R21 · FY2024 · AI
Regulation of TLR signaling in anti-commensal B cell responses and mucosal inflammation$216,625
R21 · FY2024 · AI · contact PI
Immune Signatures and Clinical Outcomes in Acute Pancreatitis$757,597
R01 · FY2023 · DK
LITAF regulation of cell death and inflammatory responses$299,631
R56 · FY2023 · AI · contact PI
Regulation of TLR signaling in anti-commensal B cell responses and mucosal inflammation$259,950
R21 · FY2023 · AI · contact PI
alpha v integrin regulation of B cell tolerance$200,000
R56 · FY2021 · AI · contact PI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis$510,000
R33 · FY2019 · AI · contact PI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis$510,000
R33 · FY2018 · AI · contact PI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis$510,000
R33 · FY2017 · AI · contact PI
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease$486,288
R33 · FY2016 · AI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis$261,000
R21 · FY2016 · AI · contact PI
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease$499,889
R33 · FY2015 · AI
Dendritic Cell Control of Intestinal T Cell Responses$371,925
R01 · FY2015 · DK · contact PI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis$217,500
R21 · FY2015 · AI · contact PI
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease$513,000
R33 · FY2014 · AI
Dendritic Cell Control of Intestinal T Cell Responses$371,925
R01 · FY2014 · DK · contact PI
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease$248,902
R21 · FY2013 · AI
Dendritic Cell Control of Intestinal T Cell Responses$226,615
R01 · FY2013 · DK · contact PI
Dendritic Cell Control of Intestinal T Cell Responses$114,832
R01 · FY2013 · DK · contact PI
Dendritic Cell Control of Intestinal T Cell Responses$356,385
R01 · FY2012 · DK · contact PI
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease$214,709
R21 · FY2012 · AI
2011 Apoptotic Cell Recognition and Clearance Gordon Research Conference and Gord$9,656
R13 · FY2011 · AI · contact PI
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses$772,657
U01 · FY2010 · AI · contact PI